| Name: | Ascendis Pharma Endocrinology, Inc. |
| Jurisdiction: | Alaska |
| Legal type: | Business Corporation |
| Status: | Good Standing |
| Date of registration: | 30 Mar 2021 (4 years ago) |
| Entity Number: | 10159547 |
| Place of Formation: | DELAWARE |
| Address: | 902 CARNEGIE CENTER, SUITE 301, PRINCETON, NJ 08540 |
Line of Business
31-33 ManufacturingNAICS
325412 PHARMACEUTICAL PREPARATION MANUFACTURING| Name | Role |
|---|---|
| Jan Moller Mikkelsen | Director |
| Jan Moller Mikkelsen | President |
| Scott Thomas Smith | Treasurer |
| Scott Thomas Smith | Vice President |
| UNITED AGENT GROUP INC. | Registered Agent |
| Type | License Number | Status | Date of issue | Date of renewal | Expiration date | Description |
|---|---|---|---|---|---|---|
| Business License | 2156488 | Active | 2022-05-10 | 2024-05-07 | 2025-12-31 | LOB: 31-33 - Manufacturing, NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING |
| Manufacturer | 183217 | Active | 2021-08-31 | - | 2026-06-30 | - |
Date of last update: 11 Jan 2025
Sources: State of Alaska - Department of Commerce, Community, and Economic Development
